苄基四氢巴马汀细胞内用药对豚鼠乳头状肌动作电位和 心室肌细胞延迟整流钾电流的作用

目的　研究将苄基四氢巴马汀 (BTHP)导入细胞内对豚鼠乳头状肌动作电位及单个心室肌细胞延迟整流钾电流的影响。方法　利用外加电压脉冲将药物导入乳头状肌细胞内 ,并用标准微电极方法测定动作电位 ;利用浓度差扩散方式使药物进入单个心室肌细胞内 ,采用全细胞膜片钳技术记录延迟整流钾电流 (IK)。结果　 10 0 μmol·L-1BTHP使APD2 0 和APD90 分别延长 13 5 %和 2 0 5 %。 30 μmol·L-1BTHP使IK 和IK ,tail分别从 (14 1± 2 2 )pA·pF-1和 (4 0± 0 6 ) pA·pF-1降至 (9 4± 1 3) pA·pF-1和 (2 1± 1 0 ) pA·pF-1,下降率分别为 33 2 %和 35 3%。该药使IK 和IK ,tail的I V曲线幅度降低 ,对曲线形状影响不明显。结论　BTHP入细胞内后可阻滞延迟整流钾电流和延长动作电位时程。     

苄基四氢巴马汀对大鼠心室肌细胞瞬时外向钾电流的影响

利用全细胞膜片钳技术测定大鼠心室肌细胞的Ito,研究苄基四氢巴马汀 (BTHP)对大鼠心室肌瞬时外向钾电流 (Ito)的影响 .结果显示 ,5 .0 μmol·L- 1BTHP可以降低Ito,使Ito幅值从 (13.8± 2 .2 )pA·pF- 1降至 (5 .1± 1.4 )pA·pF- 1(P <0 .0 1) .在 1～ 10 0μmol·L- 1范围内BTHP的作用呈浓度依赖性 ,IC50 为3.6μmol·L- 1,该药不改变Ito电流 电压曲线的形状 ,而使电流幅值减少 .5 .0 μmol·L- 1BTHP使稳态激活曲线右移 ,半激活电压 (V1/2 )从 (- 6.8±0 .2 )mV移至 (- 1.5± 0 .1)mV ,但曲线斜率基本不变 .BTHP对失活曲线影响不大 ,5 .0 μmol·L- 1BTHP使通道失活后恢复时间常数从 (75± 19)ms延长为(119± 2 1)ms(P <0 .0 1) .结果说明 ,BTHP浓度依赖地阻滞大鼠心室肌细胞的Ito.     

苄基四氢巴马汀对心室肌动作电位和延迟整流钾电流的频率依赖性作用

目的　研究BTHP对豚鼠乳头状肌动作电位及单个心室肌细胞延迟整流钾电流影响的频率依赖性。方法　用标准微电极方法在不同基础周长 (BCL)时测定动作电位 ;采用全细胞膜片钳技术测定延迟整流钾电流 (IK:IKr、IKs)。结果　 10 0 μmol·L-1BTHP在BCL为 :2 0 0 0、2 5 0ms时 ,使APD2 0 分别延长 11 35 %和 2 5 5 5 % ;使APD90 分别延长15 97%和 32 5 6 %。 30 μmol·L-1BTHP在刺激频率为 :0 2 5和 2 0Hz时分别使Ikr,tial从 (0 94± 0 .44 ) pA·pF-1和(0 92± 0 31) pA·pF-1降至 (0 6 0± 0 32 ) pA·pF-1和 (0 43± 0 18)pA·pF-1。在刺激频率为 :0 1和 2 0Hz时分别使Iks,tial从 (4 2 2± 0 5 6 ) pA·pF-1和 (5 14± 0 2 8)降至 (2 5 8±0 41)pA·pF-1和 (2 6 2± 0 37)pA·pF-1。结论　BTHP可频率依赖性地阻滞IKr、IKs,其延长动作电位也呈频率依赖性     

苄基四氢巴马汀对豚鼠心室肌细胞慢激活延迟整流钾电流及其尾电流的作用(英文)

目的　研究苄基四氢巴马汀 (BTHP)的抗心律失常机理。方法　采用全细胞膜片钳技术记录心室肌细胞慢激活延迟整流钾电流 (IKs)及其尾电流(IKs ,tail)。结果　BTHP在 1～ 10 0 μmol·L- 1的范围内以浓度依赖性、电压依赖性和频率依赖性方式阻滞IKs ,tail,其IC50 为 9.3μmol·L- 1(95 %可信限 :7.8～11.8μmol·L- 1)。BTHP 30 μmol·L- 1可使IKs 及IKs,tail分别降低 (40± 6 ) %和 (39± 5 ) % (P <0 .0 1)。BTHP可以抑制IKs ,tail。该药主要使IKs ,tail的失活时间常数缩短 ,从而使IKs ,tail 失活速度增加 ,而对IKs,tail的激活动力学影响不大。结论　BTHP对IKs有明显的抑制作用。     

N-甲基小檗胺对人心房肌细胞瞬时外向钾电流和延迟整流钾电流的作用(英文)

目的　动物实验表明N 甲基小檗胺 (NMB)通过抑制豚鼠心室肌细胞ATP敏感性钾电流和钙电流来发挥抗心律失常和抗心肌缺血作用 ,故进一步研究NMB对人心肌细胞电流的作用。方法　膜片钳制技术全细胞记录模式研究NMB对人心房肌细胞瞬时外向钾电流 (Ito)和延迟整流钾电流 (IK)的作用。结果　指令电位为 +60mV时 ,NMB 0 .1 ,1 ,1 0 μmol·L-1 分别使Ito幅值下降 (1 6± 4) % ,(2 5±4) %和 (49± 3) % ,使IK 幅值下降 (42± 6) % ,(47±7) %和(65± 3) %。结论　NMB对人心房肌细胞Ito和IK 均有抑制作用。     

黄连素对结肠平滑肌细胞膜钙激活钾通道和延迟整流钾通道的影响

目的　研究黄连素对结肠平滑肌细胞膜钙离子激活钾通道 (IK(Ca) )和延迟整流钾通道 (IK(V) )的影响以初步探讨其治疗运动性腹泻的机制。方法　酶解法急性分离单个豚鼠结肠平滑肌细胞 ,运用膜片钳方法检测 10、5 0、10 0 μmol·L-1的黄连素对结肠平滑肌细胞膜IK(Ca) 和IK(V) 的影响。结果　 10、5 0、10 0 μmol·L-1的黄连素可抑制豚鼠单个结肠平滑肌细胞膜IK(Ca) (P <0 0 1) ,当阶跃刺激为 +80mV时 ,其IK(Ca) 分别为生理盐水对照组的 (6 8 2 0± 5 17) % ,(5 5 89± 1 6 1) % ,(4 8 0 8± 2 4 5 ) % (P <0 0 1) ;10、5 0、10 0 μmol·L-1的黄连素可抑制豚鼠单个结肠平滑肌细胞膜IK(V) (P <0 0 1) ,当阶跃刺激为 +80mV时 ,其IK(V) 分别为生理盐水对照组的 (77 0 6± 6 4 2 ) % ,(6 8 6 7± 6 79) % ,(6 1 0 7±7 72 ) % (P <0 0 1)。结论　Ber能抑制豚鼠结肠平滑肌钙离子激活钾通道和延迟整流钾通道的开放 ,这可能是其治疗运动性腹泻的机制之一。     

苄基四氢巴马汀对豚鼠心室肌细胞钾电流及钙、钠电流的作用──谨以此文献给尊敬的老师江明性教授80寿辰

目的:研究苄基四氢巴马汀(BTHP)对心肌细胞的作用特点,以探讨其抗心律失常机制。方法:用全细胞膜片钳技术考察BTHP对心室肌细胞钾电流及钙、钠电流的作用。结果:BTHP30μmol·L-1明显阻滞延迟整流钾电流(IK包括:IKr及IKs)。可使IKr及IKr,tail的幅值下降,且对IKr阻滞作用呈频率依赖性;对IKs及IKs,tail幅值也有明显的抑制作用。BTHP200μmol·L-1可明显阻滞ICa,L,使其电流幅值降低,但对IK1,ICa,T,INa电流均无影响。结论:BTHP可明显阻滞心室肌细胞IKr,IKs,ICa,L电流,且对IKr阻滞作用呈频率依赖性。     

环维黄杨星D延长大鼠心室肌细胞APD作用的分子机制研究

目的　研究环维黄杨星D对分离的大鼠心室肌细胞内向整流钾电流 (IK1 )、瞬时外向钾电流 (Ito)、L 型钙电流(ICa L)和动作电位时程 (APD)的影响。方法　采用全细胞膜片钳技术记录大鼠心室肌细胞IK1 、Ito、ICa L 和APD。结果　 1和10 μmol·L- 1 环维黄杨星D明显延长分离大鼠心室肌细胞APD50 和APD90 ,10 μmol·L- 1 可明显降低静息膜电位 (RP)。环维黄杨星D对IK1 内向电流和外向电流均有明显抑制作用 ,当指令电压为 - 10 0mV时 ,1和 10 μmol·L- 1 环维黄杨星D分别使IK1 电流密度从给药前的 ( - 8.0± 1.1)pA pF降至 ( - 4 .1± 0 .7)pA pF和 ( - 3.4± 0 .8)pA pF ;当指令电压 - 30mV时 ,分别使IK1 电流密度从 ( 1.10± 0 .2 4 )pA pF降至 ( 0 .6 1± 0 .18)pA pF和 ( 0 .36± 0 .11)pA pF ;在钳制电位从 0到 + 6 0mV之间 ,环维黄杨星D明显抑制Ito,当指令电压 4 0mV时 ,1和 10 μmol·L- 1 环维黄杨星D分别使Ito电流密度从给药前的 ( 8.9± 2 .0 )pA pF降至 ( 5 .5± 1.2 )pA pF和 ( 4 .9± 0 .9)pA pF。环维黄杨星D浓度依赖性抑制ICa L,在指令电压为 10mV时 ,1和 10 μmol·L- 1 分别使ICa L电流密度从给药前的 ( - 9.9± 1.8)pA pF降至 ( - 6 .4± 1.4 )pA pF和 ( - 4 .2± 0 .6 )pA pF。结论　环     

冬虫夏草水提液对单个心室肌细胞钾通道的影响

目的　观察冬虫夏草水提液对豚鼠及大鼠心室肌细胞钾通道的作用 ,探讨冬虫夏草的抗心律失常作用机制。方法　应用全细胞膜片钳技术记录冬虫夏草水提物对豚鼠单个心室肌细胞内向整流钾电流 (IK1)、延迟整流钾电流 (IK)及大鼠心室肌细胞瞬时外向钾电流 (Ito)的影响。结果　应用 0 1g·L-1(生药浓度 )冬虫夏草水提液使豚鼠单个心室肌细胞内向整流钾电流在实验电压 - 12 0mV时从给药前(- 36 37± 5 15 ) pA/pF减少到 (- 2 9 70± 5 90 ) pA/ pF(n=5 ,P <0 0 5 ) ;延迟整流钾电流在实验电压 +70mV时 ,从给药前 (9 2 1± 2 4 2 ) pA/ pF增加至 (11 5 4± 2 98)pA/ pF(n =6 ,P <0 0 1) ;使大鼠心室肌细胞瞬时外向钾电流 (Ito)在实验电压 +5 0mV时 ,从给药前 (13 36± 0 88) pA/ pF增加至 (16 4 8± 1 0 9) (n =4 ,P <0 0 1)。结论　冬虫夏草抗心律失常作用与它对心肌细胞钾通道的作用有关。它增加IK,Ito的同时抑制IK1,将会使动作电位时程缩短而不至于发生早后除极和迟后除极     

盐酸非洛普对豚鼠心室肌细胞延迟整流钾电流的抑制作用

目的　已知盐酸非洛普〔1 (2 ,6 二甲基苯氧基 ) 2 (3,4 二甲氧基苯乙氨基 )丙烷盐酸盐 ,DDPH〕对心肌钙电流和钠电流具有抑制作用 ,为全面了解其抗心律失常作用的离子机理 ,研究其对延迟整流钾电流的影响。方法　全细胞膜片钳技术记录豚鼠心室肌细胞快激活的延迟整流钾电流的尾电流(IKr tail)和慢激活的延迟整流钾电流 (IKs)及其尾电流 (IKs tail)。结果　DDPH(1～ 10 0 μmol·L- 1)浓度依赖性地抑制IKr tail,其IC50 为 7.0 (95 %可信限为4 .2 3～ 9.76 ) μmol·L- 1;DDPH 10 μmol·L- 1对IKr tail具有电压依赖性抑制作用。DDPH 10 ,30和 10 0 μmol·L- 1可浓度依赖性地抑制IKs及其IKs tail,使IKs从给药前的 (9.1± 0 .7)pA·pF- 1分别降至 (7.7± 1.7) ,(7.5± 1.8)和 (5 .6± 1.8)pA·pF- 1(P <0 .0 1) ;使IKs tail从给药前的 (1.4± 0 .2 )pA·pF- 1分别降至(1.1± 0 .2 ) ,(0 .9± 0 .2 )和 (0 .6± 0 .2 )pA·pF- 1(P <0 .0 5或P <0 .0 1) ;DDPH 30 μmol·L- 1对IKs tail具有电压依赖性抑制作用。结论　DDPH对豚鼠心室肌细胞延迟整钾电流具有抑制作用。     

Efficacy of gut lavage,hemodialysis, and hemoperfusion in the therapy of paraquat or diquat intoxication

Clinical and in vitro investigations were carried out to test the efficacy of gut lavage, hemodialysis, and hemoperfusion in the treatment of poisoning with paraquat or diquat. In a patient suffering from diquat intoxication 130 times more diquat was removed by gut lavage 30 h after ingestion than was removed by complete aspiration of the gastric contents.Determination of in vitro clearances for paraquat and diquat by hemodialysis showed that, at serum concentrations of 1–2 ppm, such as are frequently encountered in poisoning in man, toxicologically relevant quantities of herbicide cannot be removed from the body. At a concentration of 20 ppm, on the other hand, hemodialysis proved to be effective, the clearance being 70 ml/min at a blood flow rate of 100 ml/min. The efficacy of hemoperfusion with coated activated charcoal was on the whole better. Especially at concentrations around 1–2 ppm, the clearance values for hemoperfusion were some 5–7 times higher than those for hemodialysis.In a patient suffering from paraquat poisoning, both hemodialysis as well as hemoperfusion were carried out. The in vitro results could be confirmed: At serum concentrations of paraquat less than 1 ppm no clearance could be obtained by hemodialysis while by hemoperfusion with activated charcoal quite high clearance values were measured and the serum level dropped down to zero.

---

Zusammenfassung Klinische Untersuchungen und Laboratoriumsversuche wurden durchgeführt, um die Wirksamkeit von Darmspülung, Hämodialyse und Hämoperfusion bei Paraquat- und Deiquat-Vergiftungen zu prüfen.Bei einem Patienten wurde 30 Std nach Deiquat-Aufnahme durch Darmspülung 130mal mehr Deiquat entfernt als durch vollständige Aspiration des Mageninhaltes. In vitro-Versuche ergaben, daß bei Blutserumkonzentrationen von 1–2 ppm, die bei Vergiftungen oft gemessen werden, durch Hämodialyse keine toxikologisch relevanten Paraquat- oder Deiquat-Mengen entfernt werden können. Dagegen erwies sich die Hämodialyse bei 20 ppm und einer Blutumlaufgeschwindigkeit von 100 ml/min mit einer Clearance von 70 ml/min als wirksam. Die Hämoperfusion mit beschicheter Aktivkohle war in diesen Versuchen aber eindeutig überlegen, denn insbesondere bei Konzentrationen um 1–2 ppm waren die Clearance-Werte 5–7mal höher als bei der Hämodialyse.Die in vitro-Ergebnisse wurden bei einem Patienten mit einer Paraquat-Vergiftung bestätigt: Bei Konzentrationen unter 1 ppm war die Hämodialyse wirkungslos, während durch Hämoperfusion relativ hohe Clearance-Werte erreicht wurden, so daß der Serumspiegel rasch unter die Nachweisgrenze abfiel.

     

In vitro studies on sterically stabilized liposomes (SL) as enzyme carriers in organophosphorus (OP) antagonism

This study describes a new approach for organophosphorous (OP) antidotal treatment by encapsulating an OP hydrolyzing enzyme, OPA anhydrolase (OPAA), within sterically stabilized liposomes. The recombinant OPAA enzyme was derived from Alteromonas strain JD6. It has broad substrate specificity to a wide range of OP compounds: DFP and the nerve agents, soman and sarin. Liposomes encapsulating OPAA (SL)* were made by mechanical dispersion method. Hydrolysis of DFP by (SL)* was measured by following an increase of fluoride ion concentration using a fluoride ion selective electrode. OPAA entrapped in the carrier liposomes rapidly hydrolyze DFP, with the rate of DFP hydrolysis directly proportional to the amount of (SL)* added to the solution. Liposomal carriers containing no enzyme did not hydrolyze DFP. The reaction was linear and the rate of hydrolysis was first order in the substrate. This enzyme carrier system serves as a biodegradable protective environment for the recombinant OP-metabolizing enzyme, OPAA, resulting in prolongation of enzymatic concentration in the body. These studies suggest that the protection of OP intoxication can be strikingly enhanced by adding OPAA encapsulated within (SL)* to pralidoxime and atropine.     

Aquatic Insects and Trace Metals: Bioavailability,Bioaccumulation, and Toxicity

Abstract

The uptake of metals from food and water sources by insects is thought to be additive. For a given metal, the proportions taken up from water and food will depend both on the bioavailable concentration of the metal associated with each source and the mechanism and rate by which the metal enters the insect. Attempts to correlate insect trace metal concentrations with the trophic level of insects should be made with a knowledge of the feeding relationships of the individual taxa concerned. Pathways for the uptake of essential metals, such as copper and zinc, exist at the cellular level, and other nonessential metals, such as cadmium, also appear to enter via these routes. Within cells, trace metals can be bound to proteins or stored in granules. The internal distribution of metals among body tissues is very heterogeneous, and distribution patterns tend to be both metal and taxon specific. Trace metals associated with insects can be both bound on the surface of their chitinous exoskeleton and incorporated into body tissues. The quantities of trace meals accumulated by an individual reflect the net balance between the rate of metal influx from both dissolved and particulate sources and the rate of metal efflux from the organism. The toxicity of metals has been demonstrated at all levels of biological organization: cell, tissue, individual, population, and community. Much of the literature pertaining to the toxic effects of metals on aquatic insects is based on laboratory observations and, as such, it is difficult to extrapolate the data to insects in nature. The few experimental studies in nature suggest that trace metal contaminants can affect both the distribution and the abundance of aquatic insects. Insects have a largely unexploited potential as biomonitors of metal contamination in nature. A better understanding of the physico-chemical and biological mechanisms mediating trace metal bioavailability and exchange will facilitate the development of general predictive models relating trace metal concentrations in insects to those in their environment. Such models will facilitate the use of insects as contaminant biomonitors.     

Pharmacological treatment of COVID-19: an opinion paper

The precocity and efficacy of the vaccines developed so far against COVID-19 has been the most significant and saving advance against the pandemic. The development of vaccines has not prevented, during the whole period of the pandemic, the constant search for therapeutic medicines, both among existing drugs with different indications and in the development of new drugs. The Scientific Committee of the COVID-19 of the Illustrious College of Physicians of Madrid wanted to offer an early, simplified and critical approach to these new drugs, to new developments in immunotherapy and to what has been learned from the immune response modulators already known and which have proven effective against the virus, in order to help understand the current situation.     

Alzheimer’s disease – current trends in basic and clinical research. Highlights from the 16th ECNP

Advances in the molecular biological knowledge of neuronal nicotinic acetylcholine receptors (nAChRs) have led to a growing interest by the pharmaceutical industry in the development of novel compounds that selectively modulate nAChR function. The ability of (-)-nicotine, an activator of nAChRs, to enhance attentional aspects of cognition in animals and humans, to exert neuroprotective and anxiolytic-like effects, and presumably to mediate the negative correlation between smoking and Alzheimer's (and Parkinson's) Disease, has focused interest on the potential therapeutic utility of modulators of nAChR function for treatment of some of the deficits associated with these progressive, neurodegenerative conditions. Numerous compounds are known which activate nAChRs and which might serve as lead compounds toward the development of such agents. The pharmacologic diversity of neuronal nAChR subtypes suggests the possibility of developing selective compounds which would have more favourable side-effect profiles than existing agents. This broader class of agents, collectively called cholinergic channel modulators (ChCMs), is anticipated to encompass compounds which would have more favourable side-effect profiles than existing agents, which generally exhibit low selectivity. This selectivity may be achieved by preferentially activating some subtypes of nAChRs (i.e., Cholinergic Channel Activators, ChCAs) or inhibiting the function of other subtypes (Cholinergic Channel Inhibitors, ChCIs). An overview of the biology of nAChRs and the rationale for the use of ChCMs for the treatment of dementia related to neurodegenerative diseases are presented, followed by a discussion of lead compounds and compounds under consideration for clinical evaluation.     

Steroidal sapogenin contents in some domestic plants

In order to find out the values of the steroid resources for the future use. the compositions and contents of steroidal sapogenins from 13 domestic plants have been investigated. As a result,Dioscorea nipponica, D. quinqueloba andSmilax china were found to have large amount of diosgenin. And pennogenin inTrillium kamtschaticum andParis verticillata, yuccagenin inAllium fistulosum, hecogenin inAgave americana and neochlorogenin inSolanum nigum were appeared to be major steroidal sapogenins.